The first Neurocrine Biosciences trade was made in Q1 2015.
Since then Steven Cohen bought shares sixteen more times and sold shares on sixteen occasions. The investor completely sold their stake between Q4 2023 and Q2 2024.
Avg closing price
Price range
Sold -837 Thousand shares
Q2 2024
Avg closing price
$137.14
Price range
$130.86
-
$143.19
Sold 39.8% shares (-555 Thousand shares)
Q1 2024
Avg closing price
$136.57
Price range
$130.40
-
$143.74
Sold 46.0% shares (-1.19 Million shares)
Q4 2023
Avg closing price
$115.11
Price range
$106.07
-
$132.76
Increased shares by 2215.2% (+2.47 Million shares)
Q3 2023
Avg closing price
$105.30
Price range
$94.02
-
$117.10
New holding (+111 Thousand shares)
Q2 2023
Avg closing price
$97.71
Price range
$89.53
-
$104.87
Sold -665 Thousand shares
Q3 2022
Avg closing price
$101.46
Price range
$92.03
-
$107.81
Increased shares by 15.1% (+87.4 Thousand shares)
Q2 2022
Avg closing price
$92.29
Price range
$75.79
-
$100.07
Increased shares by 9.5% (+50.1 Thousand shares)
Q1 2022
Avg closing price
$84.75
Price range
$72.45
-
$94.81
Increased shares by 254.3% (+379 Thousand shares)
Q4 2021
Avg closing price
$91.99
Price range
$79.65
-
$106.22
New holding (+149 Thousand shares)
Q3 2021
Avg closing price
$94.46
Price range
$86.18
-
$99.03
Sold -22.7 Thousand shares
Q1 2021
Avg closing price
$104.86
Price range
$87.57
-
$119.40
New holding (+22.7 Thousand shares)
Q4 2020
Avg closing price
$96.59
Price range
$86.91
-
$108.33
Sold -18.1 Thousand shares
Q2 2020
Avg closing price
$110.51
Price range
$85.09
-
$130.36
Sold 69.8% shares (-41.9 Thousand shares)
Q1 2020
Avg closing price
$97.87
Price range
$75.11
-
$113.76
Increased shares by 103.1% (+30.5 Thousand shares)
Q4 2019
Avg closing price
$104.70
Price range
$86.80
-
$118.57
Sold 97.4% shares (-1.1 Million shares)
Q3 2019
Avg closing price
$93.43
Price range
$83.82
-
$101.50
Increased shares by 189.4% (+736 Thousand shares)
Q2 2019